Comparison between the Golghand majun and Polyethylene glycol in the pediatric constipatio

Phase 3

Recruiting

Conditions: Functional constipation.
Other constipation
K59.09

Registration Number: IRCT20190410043224N1

Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

Functional constipation confirmed by ROMAN criteria 4
Stool elimination twice a week or less
History of stool retention
Stiff or painful intestinal function
History of large stool diameter
History of large stool mass in rectum

Exclusion Criteria

Patients with causes of organic constipation such as celiac disease, pseudo-obstruction, hypothyroidism, spinabifida, anorectal malformation, hirschsprung's disease
Patients with chronic illness who need special care such as: stone kidney, sickle cell anemia, cereberal palsy, hepatitis, hematologic diseases, gastrointestinal bleeding, relapse fever or fever without locolized sign
Pregnanccy
History of surgery involvig the gastrointestinal tract exept for appendectomy
History of allergies or drug allergies
Diagnosis of autism, major psychosis disorder such as bipolar disorder, schizophrenia, children who have experienced physical abuse and sexual abuse
Use of medication such as Metoclopyramide, Erythromycin, Butanol, Amoxiclav, Azithromycin, Domperidone, Amitriptyline, Hyoscyamine, Clonidine, Baclofen, Dicyclomine, Scopolamine
Weight loss over five percent in the past three monthes
Use of drugs that have an unknown delay in the gastrointestinal tract

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Constipation improvement. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Clinical Examination; Questionnaire of Constipation Evaluation.

Secondary Outcome Measures

Name	Time	Method
Treatment side effects. Timepoint: During the study and 8 weeks after the intervention. Method of measurement: Clinical Examination; Questionnaire of Constipation Evaluation.